DOW:IGWall Street Cash ($10) Analysis
Data as of 2026-03-14 - not real-time
$36.62
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Dow Inc. is trading well above its 20‑day, 50‑day and 200‑day moving averages, indicating strong bullish momentum, while the RSI sits near the upper‑mid‑range at 69, suggesting continued buying pressure without yet being overbought. MACD is in a bullish configuration, and volume is on an upward trend, reinforcing the technical upside. However, the stock is priced near its recent resistance around $37.75 and sits above the consensus 12‑month target of $35, implying a potential short‑term ceiling. Volatility remains elevated at over 50% on a 30‑day basis, and the computed beta exceeds 1.4, pointing to heightened sensitivity to market swings. On the fundamentals side, revenue has contracted by roughly 9% and profit margins are negative, with a trailing EPS of –3.70 and a forward EPS that barely turns positive. The balance sheet is heavily leveraged, featuring a debt‑to‑equity ratio above 110 and free cash flow in the red, raising concerns about financial flexibility. Despite these challenges, Dow offers an attractive dividend yield of 4.78%, but the payout ratio is modest and the sustainability of the dividend is doubtful given the cash‑flow profile. Analyst sentiment leans toward a “buy” with a median price target of $35, yet the market price of $36.62 already exceeds that level, suggesting the stock may be overvalued at current levels. Recent news highlights a dramatic 40% YTD rally driven by a restructuring program, but the underlying earnings weakness tempers enthusiasm. Overall, the technical picture is strong, but fundamental and valuation pressures introduce significant risk as the rally continues.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance
- High valuation relative to analyst targets
- Elevated volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators and rising volume
- Restructuring program expected to improve earnings
- Attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Heavy debt load and negative free cash flow
- Persistent earnings deficits and low margins
- Potential overvaluation if turnaround stalls
Key Metrics & Analysis
Financial Health
Revenue Growth-9.10%
Profit Margin-6.56%
P/E Ratio49.9
ROE-13.82%
ROA-0.07%
Debt/Equity111.87
P/B Ratio1.6
Op. Cash Flow$1.0B
Free Cash Flow$-784750016
Technical Analysis
TrendBullish
RSI69.3
Support$29.20
Resistance$37.75
MA 20$32.34
MA 50$29.91
MA 200$25.96
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price$35.12
Upside/Downside-4.10%
GradeOvervalued
TypeBlend
Dividend Yield4.78%
Risk Assessment
Beta1.47
Volatility54.19%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.